We use cookies to ensure that we give you the best experience on our website. By continuing your visit on the website, you consent to the use of the cookies. If you want to find out more about the cookies we use, you can access our Privacy Policy.
After graduating from BYU, Stephen has charted an unusual path in the biotech industry. He’ll talk about this journey, career options in the biopharma space, and what he’s up to now at Curebase.
Stephen is an Associate Director of Business Development at Curebase, a fast-growing startup that’s running the next generation of clinical trials.
About this event
After graduating from BYU, Stephen has charted an unusual path in the biotech industry. He’ll talk about this journey, career options in the biopharma space, and what he’s up to now at Curebase.
Stephen is an Associate Director of Business Development at Curebase, a fast-growing startup that’s running the next generation of clinical trials. Earlier this year, Curebase raised a $40M Series B with VC investors and industry partners, including Gilead Sciences. They have supported more than 60 studies to date, including multiple successful FDA submission studies.
